Clinical Trial Update: Efficacy of Ipragliflozin Compared With Sitagliptin in Uncontrolled Type 2 Diabetes With Sulfonylurea and Metformin [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing ipragliflozin to sitagliptin in adults with uncontrolled type 2 diabetes on sulfonylurea and metformin has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)
• ipragliflozin (ipragliflozin)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED